Emily Eichenberger, MD

Start Year
2018

Education and Training

College/University
Dartmouth College

Medical School
Duke University School of Medicine

Residency
New York Presbyterian - Weill Cornell Medical Center

Career and Research Goals

My goal is to provide excellent patient and to become an independent physician scientist focusing on improving outcomes from bacterial bloodstream infections in solid organ transplant recipients.

Honors, awards and distinctions

  • Chief Resident at Memorial Sloan Kettering Cancer Center (2017-2018)
  • Member of the Robert J. Lefkowitz Society
  • Infectious Disease Society of America Medical Student Scholarship (2012)

What are the strengths of the Duke program?

As a fellow in Infectious Disease at Duke I have been afforded the opportunity to work with and train under global leaders in Infectious Disease. From the rigorous clinical training to the exceptional mentorship, Duke has been a wonderful place to learn, grow and prepare for the next step of my career.

Publications

Saullo, Jennifer L., Arthur W. Baker, Laurie D. Snyder, John M. Reynolds, Lorenzo Zaffiri, Emily M. Eichenberger, Alana Ferrari, et al. “Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis.” J Heart Lung Transplant 41, no. 4 (April 2022): 508–15. https://doi.org/10.1016/j.healun.2021.12.005.

PMID
35031206
Full Text

Sinclair, Matthew R., Maria Souli, Felicia Ruffin, Lawrence P. Park, Michael Dagher, Emily M. Eichenberger, Stacey A. Maskarinec, et al. “Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.” Am J Kidney Dis 79, no. 3 (March 2022): 393-403.e1. https://doi.org/10.1053/j.ajkd.2021.06.018.

PMID
34303771
Full Text

Eichenberger, Emily M., Felicia Ruffin, Batu Sharma-Kuinkel, Michael Dagher, Lawrence Park, Celia Kohler, Matthew R. Sinclair, Stacey A. Maskarinec, and Vance G. Fowler. “Bacterial genotype and clinical outcomes in solid organ transplant recipients with Staphylococcus aureus bacteremia.” Transpl Infect Dis 23, no. 6 (December 2021): e13730. https://doi.org/10.1111/tid.13730.

PMID
34500502
Full Text

Dagher, Michael M., Emily M. Eichenberger, Kateena L. Addae-Konadu, Sarah K. Dotters-Katz, Celia L. Kohler, Vance G. Fowler, and Jerome J. Federspiel. “Maternal and Fetal Outcomes Associated With Infective Endocarditis in Pregnancy.” Clin Infect Dis 73, no. 9 (November 2, 2021): 1571–79. https://doi.org/10.1093/cid/ciab533.

PMID
34111290
Full Text

Eichenberger, Emily M., Michael Dagher, Matthew R. Sinclair, Stacey A. Maskarinec, Vance G. Fowler, and Jerome J. Federspiel. “Infective endocarditis and solid organ transplantation: Only worse outcomes during initial transplantation hospitalization.” Am Heart J 240 (October 2021): 63–72. https://doi.org/10.1016/j.ahj.2021.06.007.

PMID
34157299
Full Text

Eichenberger, Emily M., Daniel R. Kaul, and Cameron R. Wolfe. “The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors.” Transpl Infect Dis 23, no. 5 (October 2021): e13727. https://doi.org/10.1111/tid.13727.

PMID
34612553
Full Text

Choi, Seong-Ho, Michael Dagher, Felicia Ruffin, Lawrence P. Park, Batu K. Sharma-Kuinkel, Maria Souli, Alison M. Morse, et al. “Risk Factors for Recurrent Staphylococcus aureus Bacteremia.” Clin Infect Dis 72, no. 11 (June 1, 2021): 1891–99. https://doi.org/10.1093/cid/ciaa801.

PMID
32564065
Full Text

Eichenberger, Emily M., Felicia Ruffin, Michael Dagher, Reginald Lerebours, Sin-Ho Jung, Batu Sharma-Kuinkel, Andrew N. Macintyre, et al. “Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.” Am J Transplant 21, no. 6 (June 2021): 2113–22. https://doi.org/10.1111/ajt.16388.

PMID
33131212
Full Text

Eichenberger, Emily M., Michael Dagher, Felicia Ruffin, Lawrence Park, Lisa Hersh, Sumathi Sivapalasingam, Vance G. Fowler, and Brinda C. Prasad. “Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria.” Eur J Clin Microbiol Infect Dis 39, no. 11 (November 2020): 2121–31. https://doi.org/10.1007/s10096-020-03955-z.

PMID
32621149
Full Text

Maskarinec, S. A., L. P. Park, F. Ruffin, N. A. Turner, N. Patel, E. M. Eichenberger, D. van Duin, T. Lodise, V. G. Fowler, and J. T. Thaden. “Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia.” Clin Microbiol Infect 26, no. 7 (July 2020): 904–10. https://doi.org/10.1016/j.cmi.2020.01.025.

PMID
32114010
Full Text

Pages